1Fletcher CDM,Unni KK,Mertens F.WHO classification of Tumours:Pathology Genetics of tumours of soft tissue and bone[M].Lyon:IARC Press,2002.1-224.
2Chang CC,Liu YC,CIeveland RP,et al.Expression of c-Myc and p53 correlates with clinical outcome in diffuse large Bcell lymphomas[J].Am J Clin Pathol,2000,113:513-518.
3Butler M,Corbally N,Dervan PA,et al.Bcl-6 and other genomic alterations in non-Hodgkin's lymphoma(NHL)[J].Br J Cancer,1997,75:1641-1645.
4Skinnider BF,Horsman DE,Dupuis B,et al.Bcl-6 and Bcl-2protein expression in diffuse large B-cell lymphoma and follicular lymphoma:correlation with 3q27 and 18q21 chromosomal abnormalitiet[J].Hum Pathol,1999,30:803-808.
5Huang JZ,Sanger WG,Greiner TC,et al.The t(14;18)defines a unique subset of diffuse large B-cell lymphoma with a germinal B-center B-cell gene expression prlfile[J].Blood,2002,99:2285 -2290.
6Alizadeh AA,Eisen MB,Davis E,et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J].Nuture,2000,403:503-511.
7Jaffe EL,Stein H.World Health Organization Classification of tumors.Pathology and genetics of tumors of haenatopoietic and lymphoid tissues[C].Lyon:IARC Press,2001.172.
8Feller AG,Diebold J.Histopathology of nodal and extra-nodal non-Hodgkin's lymphomas[M].Berlin:Springer,2004.75-99.
